KLRS as of Nov 1 · 16:47 ET
KLRSNasdaqBiological Products, (No Diagnostic Substances)
Kalaris Therapeutics, Inc. · Brief
Next report
10 days
Nov 11 · before openest.Q3 FY26
Expected move
No implied move.
—≥ implied
Q2 FY26—▲+0.76%—
quarterimplied−5%0+5%realized×
Q2 FY26—▲+0.76%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 11 report · est.—
Linked exposure
KLRS report sessionNo linked exposure.
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.